Philips and Cellpoint in research pact for nuclear medicine
This article was originally published in Clinica
Executive Summary
Philips Medical Systems is to collaborate with biotechnology firm Cellpoint in a bid to optimise the performance of their molecular imaging equipment and provide cost-effective cancer diagnosis.